SPIB is a sequence-specific transcription factor that binds to purine-rich PU-box DNA sequences and serves critical roles in immune cell development and differentiation. SPIB is essential for the development of plasmacytoid dendritic cells (pDCs) and conventional dendritic cell type 2 (cDC2) subsets, with HDAC1-mediated regulation controlling its expression during DC differentiation 1. In the spleen, SPIB functions as a critical regulator required for white pulp fibroblastic reticular cell differentiation, homeostatic chemokine expression, and antiviral T cell responses 2. SPIB also drives the differentiation of specialized intestinal epithelial cells, including BEST4/CA7+ cells involved in fluid homeostasis and bacterial infection responses 3, and M cells that present antigens including gluten peptides 4. In cancer contexts, SPIB aberrations contribute to aggressive B-cell lymphoma pathogenesis, particularly in MYD88/BCL2-driven diffuse large B-cell lymphoma where SPIB alterations are associated with distinct molecular subtypes and therapeutic sensitivities 5. Additionally, SPIB expression is regulated by upstream factors like tsRNA-GlyGCC in colorectal cancer, influencing drug resistance through JAK1/STAT6 signaling modulation 6. These findings establish SPIB as a master regulator of immune cell differentiation with significant roles in both homeostatic immunity and disease pathogenesis.